1-4 of 4
Andrzej Hellman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Enestpath: A Phase III Study to Assess the Effect of Nilotinib Treatment Duration on Treatment-Free Remission (TFR) in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients (pts) Previously Treated with Imatinib: Interim Analysis from the First Year of Induction Phase

Delphine Rea, MD PhD, Gianantonio Rosti, MD, Nicholas C.P. Cross, PhD, Andrzej Hellman, MD PhD, Dietger Niederwieser, MD, Ester Pungolino, MD, Franca Falzetti, MD, Patrizia Pregno, MD, Ester Maria Orlandi, MD, Antonio Medina Almeida, Arpad Illes, MD PhD, Cristalina Fernandez, Luca Dezzani, Angela Pellegrino, Chiara Costantini, Claudia Walasek, Giuseppe Saglio, Juan Luis Steegmann, MD, Michele Baccarani
Journal: Blood
Blood (2015) 126 (23): 4040.
https://doi.org/10.1182/blood.V126.23.4040.4040
Published: 2015
Journal Articles

Phase 2 Study of Otlertuzumab (TRU-016), an Anti-CD37 ADAPTIR TM Protein, in Combination with Bendamustine Vs Bendamustine Alone in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL) - Updated Results

Tadeusz Robak, MD, Andrzej Hellman, Javier Loscertales, MD, Ewa Lech-Maranda, MD PhD, John M. Pagel, MD PhD, Anthony R. Mato, MD, John C. Byrd, MD, Farrukh Awan, MD MS, Holger Hebart, MD, Jose A Garcia-Marco, MD PhD, Brian T. Hill, MD PhD, Michael Hallek, MD, Scott Stromatt, Janusz Kloczko, Professor
Journal: Blood
Blood (2014) 124 (21): 5642.
https://doi.org/10.1182/blood.V124.21.5642.5642
Published: 2014
Journal Articles

Phase 2 Study Of Otlertuzumab (TRU-016), An Anti-CD37 ADAPTIR TM Protein, In Combination With Bendamustine Vs Bendamustine Alone In Patients With Relapsed Chronic Lymphocytic Leukemia (CLL)

Tadeusz Robak, Andrzej Hellman, Janusz Kloczko, Javier Loscertales, Ewa Lech-Maranda, John M. Pagel, MD, PhD, Anthony Mato, John C. Byrd, MD, Farrukh T Awan, MD, Holger Hebart, Jose A Garcia-Marco, Brian T. Hill, MD, PhD, Michael Hallek, MD, Scott Stromatt, Ulrich Jaeger
Journal: Blood
Blood (2013) 122 (21): 2860.
https://doi.org/10.1182/blood.V122.21.2860.2860
Published: 2013
Journal Articles

Palifermin Does Not Influence the Incidence and Severity of GvHD Nor Long-Term Survival of Patients with Hematological Diseases Undergoing HSCT

Barbara Nasilowska-Adamska, Agnieszka Tomaszewska, Richard M. Szydlo, Piotr Rzepecki, Anna Czyz, Joanna Manko, Miroslaw Markiewicz, Tigran Torosian, Maria Bieniaszewska, Beata Piatkowska-Jakubas, Agnieszka Wierzbowska, Dorota Duda, Andrzej Szczepinski, Andrzej Lange, Tadeusz Robak, Aleksander Skotnicki, Andrzej Hellman, Wieslaw W. Jedrzejczak, Jerzy Holowiecki, Anna Dmoszynska, Mieczyslaw Komarnicki, Krzysztof Warzocha, Bozena Marianska
Journal: Blood
Blood (2008) 112 (11): 4301.
https://doi.org/10.1182/blood.V112.11.4301.4301
Published: 2008